Journal of Obesity & Weight Loss Therapy
天美传媒 Access
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 2305
Indexed In
- Index Copernicus
- Google Scholar
- 天美传媒 J Gate
- Genamics JournalSeek
- Centre for Agriculture and Biosciences International (CABI)
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- CABI full text
- Cab direct
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- University of Bristol
- Pubmed
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
How did an albino patient lose 148 lbs of weight? A case report
6th World Congress on Obesity
Zarnain Shah, Samaneh A Motanagh and Syed Wajih Rizvi
Liaquat University of Medical & Health Sciences, Pakistan Ankara University School of Medicine, Turkey R-Endocrinology, USA
ScientificTracks Abstracts: J Obes Weight Loss Ther
DOI:
Abstract
Introduction: Obesity is a highly prevalent and yet the most neglected disease. The number of overweight and obese people reached 2.3 billion and 700 million worldwide respectively, by the year 2015. Obesity is not a social disgrace but an actual disease with a major genetic component to its etiology. Obesity treatment is a lifelong task. Weight reduction medications should be used as an adjunct to diet restriction, exercise and behavioral modifications, when these measures alone have not resulted in adequate weight loss. We hereby present a case of a morbidly obese male patient with occulocutaneous albinism who has lost 148 lbs of weight. Furthermore, the report highlights the genetic link between occulocutaneous albinism and obesity. Case Presentation: 28-year-old male with occulocutaneous albinism presented with 361.8 lbs of weight (BMI: 62.1) and complaint of difficulty in losing weight. Physical examination revealed hypertension, low intelligence, gynecomastia and infantile testicles. Lab investigations showed unregulated hyperlipidemia and hypotestosteronemia. The patient was prescribed Xenical (Orlistat) 120 mg. Over the period of five years, he lost 83.8 lbs. After this time, Xenical芒�?�?s effectiveness was significantly reduced. Consequently, the patient was started on Victoza (Liraglutide) on which he lost 64 lbs in three years. Thus, a sum of 147.8 lbs of weight was lost without any side effects of the drugs. Discussion: Obesity needs to be treated within the healthcare system as any other complex disease. We observed Xenical and Victoza to be safe and effective in reducing obesity. Substantial literature has emerged to show that in both Occulocutaneous albinism and Prader-Willi syndrome (the most common genetic cause of obesity) the P-gene is mutated on Chromosome 15. This highlights the genetic susceptibility of our albino patient for developing morbid obesity. Conclusion: Obesity develops from the interplay of both genetic and environmental factors. This case clearly illustrates that Xenical and Victoza can be safe and efficient for weight loss in a morbidly obese patient. Furthermore, scientific research in the genetic aspects of obesity can help develop new strategies towards its prevention and treatment.Biography
Zarnain Shah is a fourth-year Medical student at Liaquat University of Medical and Health Sciences, Jamshoro. Along with her extraordinary academic record, she holds a keen interest for scientific research..
Email: syedazarnain@gmail.com
